"It is true," said ministry spokesman Ivan Skrylnik. "It is made out of horse blood."
But while the drug's distributors claim that it is "almost 100 percent effective" against Ebola, the World Health Organization, or WHO, remains skeptical.
In a telephone interview, Jim Le Duc, head of the WHO special virus group, said that while experiments of the drug on rodents had been very promising, a number of monkeys had died after taking it.
"The limited quantities of the product indicated that is was not as valuable as we had hoped," Le Duc said. "It's too early to tell how good this will be on humans."
After two years of research, the Defense Ministry's Scientific Research Institute of Microbiology discovered the drug last summer and sold it to the WHO after an Ebola outbreak in Zaire last May that killed more than 150 people.
And according to Yevgeny Smirnov, commercial director of Epidbiomed, which distributed the drug to the World Health Organization, the antibody marks a breakthrough for Russian medical science.
"The Americans were working on this too," Smirnov said.
"But they didn't have results like these. There aren't very many competitive formulae in this area, so we're very happy for the team that found this," he said.
A highly contagious disease, Ebola has been more than 80 percent fatal, causing its victims to bleed internally and sometimes through pores and bodily orifices, Le Duc said.
Named after a river in northern Zaire, it belongs to a class of organisms which destroy the linings of capillaries and blood vessels, prompting fluids to drain from the circulatory system.
Along with rabies and HIV, it is considered to be one of the world's deadliest viruses.
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.